Hookipa Biotech Gmbh
Clinical trials sponsored by Hookipa Biotech Gmbh, explained in plain language.
-
New vaccine-like therapy targets HPV-driven cancers
Disease control CompletedThis study tested two experimental treatments, HB-201 and HB-202, in 198 people with HPV16-positive cancers. The goal was to see if these therapies could shrink tumors and control the disease. The treatments are designed to help the immune system attack cancer cells, but they are…
Phase: PHASE1, PHASE2 • Sponsor: Hookipa Biotech GmbH • Aim: Disease control
Last updated May 26, 2026 11:28 UTC
-
Real-world data sheds light on HPV throat cancer treatments
Knowledge-focused CompletedThis study looked at 662 patients with HPV-positive throat cancer that had spread or come back. Researchers collected information on who these patients are, what treatments they received (pembrolizumab or nivolumab, with or without chemotherapy), and how well those treatments wor…
Sponsor: Hookipa Biotech GmbH • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC